galantamine has been researched along with Movement Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pregelj, P; Saghafi, MM; Živin, M | 1 |
| SAFRAI, SE | 1 |
| Cecchini, M | 1 |
3 other study(ies) available for galantamine and Movement Disorders
| Article | Year |
|---|---|
Galantamine as a preventive of diisopropylphosphorofluoridate toxicity effects in rat brain.
Topics: Acetylcholinesterase; Animals; Body Temperature; Brain; Fasciculation; Galantamine; Gene Expression Regulation; Isoflurophate; Male; Motor Activity; Movement Disorders; Neuroprotective Agents; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; RNA, Messenger | 2013 |
[TREATMENT OF CEREBRAL PALSY IN CHILDREN WITH HYPERKINESIA AND CEREBELLAR DISORDERS].
Topics: Adolescent; Cerebellar Diseases; Cerebral Palsy; Child; Corrinoids; Drug Therapy; Electric Stimulation Therapy; Galantamine; Humans; Hyperkinesis; Infant; Movement Disorders; Vitamin B 12 | 1965 |
[Treatment of the motor sequelae of cerebral vascular diseases with galanthamine hydrobromide. Clinical report].
Topics: Cerebrovascular Disorders; Galantamine; Hemiplegia; Humans; Movement Disorders | 1966 |